Milestone Scientific Inc. (MLSS)

Market Cap	36.72M -52.9%
Revenue (ttm)	8.90M +3.4%
Net Income	-4.57M
EPS	-0.06
Shares Out	88.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	137,669
Open	0.4210
Previous Close	0.4340
Day's Range	0.3970 - 0.4232
52-Week Range	0.2181 - 0.9300
Beta	1.02
Analysts	Buy
Price Target	1.00 (+140.79%)
Earnings Date	May 13, 2026

About MLSS

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides The Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery sys...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 15
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: MLSS
• Website: https://www.milestonescientific.com

Financial Performance

In 2025, Milestone Scientific's revenue was $8.97 million, an increase of 3.99% compared to the previous year's $8.63 million. Losses were -$5.72 million, 21.4% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for MLSS stock is "Buy." The 12-month stock price target is $1.0, which is an increase of 140.79% from the latest price.

Price Target

$1.0

(140.79% upside)

Analyst Consensus: Buy